MIR6842

Across TCGA pan-cancer cohorts, MIR6842 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MIR6842 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher MIR6842 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR6842 expression acts as an unfavorable survival marker.

OV, LIHC, and DLBC are the cancer types where MIR6842 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	III,IV	0.304	0.539	<.001	54	view →
LIHC	OS	Tertile	II,III,IV	0.186	0.624	<.001	54	view →
DLBC	DFS	Tertile	II,III,IV	0.065	0.829	<.001	36	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	33	view →
SARC	DFS	Tertile	All	0.107	0.639	<.001	33	view →
READ	OS	Tertile	IV	0.111	0.893	<.001	27	view →
THYM	OS	Tertile	All	0.577	0.962	.009	18	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
ACC	DFS	Tertile	II,III,IV	0.226	0.725	.009	18	view →
HNSC	OS	Tertile	IV	0.071	0.652	<.001	18	view →
SKCM	OS	Tertile	All	0.333	0.780	.046	9	view →
KIRP	DFS	Tertile	II,III,IV	0.157	0.692	.044	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MIR6842–OV (DFS)

Open the OV breakdown →